Effects of YM-14673, a new thyroid-releasing hormone analogue, on neurological in stroke-prone spontaneously hypertensive rats-Reference-Cited by-同舟云学术

Effects of YM-14673, a new thyroid-releasing hormone analogue, on neurological in stroke-prone spontaneously hypertensive rats

Published:1991-01 Issue:1 Volume:192 Page:165-167
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Yamamoto Minoru,Sudoh Kazumi,Sasamata Masao

Publisher

Elsevier BV

Subject

Pharmacology

Reference10 articles.

1. The spread of vasogenic brain edema and its role in cerebral tissue destruction in stroke-prone spontaneously hypertensive rats;Kalimo;J. Hypert.,1986

2. Evaluation of the effects of two TRH analogues on cerebral ischemia;Latham;Regul. Pept.,1985

3. Relationship between stroke-related behavior and plasma norepinephrine concentration in stroke-prone spontaneously hypertensive rats;Minami;Jap. Heart. J.,1986

4. Effects of YM-14673 on the central nervous system — An electrophysiological study of arousal reaction and evoked muscular discharge;Naito;J. Kansai Med.,1988

5. Establishment of the stroke-prone spontaneously hypertensive rat (SHR);Okamoto;Circ. Res.,1974

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of L-pGlu-(1-benzyl)-l-His-l-Pro-NH2 against in-vitro and in-vivo models of cerebral ischemia and associated neurological disorders;Biomedicine & Pharmacotherapy;2016-12

2. Protective effects of l-pGlu-(2-propyl)-l-His-l-ProNH2, a newer thyrotropin releasing hormone analog in in vitro and in vivo models of cerebral ischemia;Peptides;2011-06

3. Synthesis, Receptor Binding, and CNS Pharmacological Studies of New Thyrotropin‐Releasing Hormone (TRH) Analogues;ChemMedChem;2011-02-07

4. Modifications of the pyroglutamic acid and histidine residues in thyrotropin-releasing hormone (TRH) yield analogs with selectivity for TRH receptor type 2 over type 1;Bioorganic & Medicinal Chemistry;2007-01-01

5. Post-stroke atorvastatin treatment reduces neurological deficits and mortality rate in the stroke-prone spontaneously hypertensive rat;Journal of Pharmacy and Pharmacology;2004-07